Regenxbio Inc. v. Sarepta Therapeutics, Inc.
Federal Circuit Affirms No Patent Infringement in Gene Therapy Dispute
cafc · 2026-02-20 · Defendant Win · Impact: 65/100
This case involves a dispute between two biotechnology companies, Regenxbio Inc. and Sarepta Therapeutics, Inc., over patent rights related to gene therapy. Regenxbio sued Sarepta, alleging that Sarep...